e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Mechanisms and treatment of virus induced asthma exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Neutrophils as a source of nitric oxide in airway inflammation of asthmatics; putative relevance to coexisting rhinovirus infections
M. Cembrzynska-Nowak, J. Liebhart, M. Bienkowska-Haba, R. Dobek, I. Siemieniec, E. Liebhart, W. Barg, A. Kulczak (Wroclaw, Poland)
Source:
Annual Congress 2004 - Mechanisms and treatment of virus induced asthma exacerbations
Session:
Mechanisms and treatment of virus induced asthma exacerbations
Session type:
Oral Presentation
Number:
3029
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Cembrzynska-Nowak, J. Liebhart, M. Bienkowska-Haba, R. Dobek, I. Siemieniec, E. Liebhart, W. Barg, A. Kulczak (Wroclaw, Poland). Neutrophils as a source of nitric oxide in airway inflammation of asthmatics; putative relevance to coexisting rhinovirus infections. Eur Respir J 2004; 24: Suppl. 48, 3029
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma
Source: Eur Respir J 2006; 27: 951-956
Year: 2006
Increased nitric oxide production by neutrophils in bronchial asthma
Source: Eur Respir J 2001; 17: 868-871
Year: 2001
Screening with exhaled nitric oxide (ENO) may identify cases with on-going bronchial inflammation but not asthma symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 38s
Year: 2001
Neurokinins and nitric oxide modulate airway remodeling in a model of lung allergic inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 578s
Year: 2005
Differential assessment of airway inflammation and anti-inflammatory treatment in asthma by measurements of exhaled nitric oxide (NO) derived from peripheral
versus
central airways
Source: Eur Respir J 2003; 22: Suppl. 45, 449s
Year: 2003
Features of production nitric oxide at patients with a bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006
Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Inhibitors of NADPH-oxidase or nitric oxide synthase prevent airway hyperresponsiveness but not allergic inflammation in mice
Source: Eur Respir J 2001; 18: Suppl. 33, 265s
Year: 2001
Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms
Source: Eur Respir J 2002; 20: 841-845
Year: 2002
Comparison of alveolar nitric oxide concentrations using two different methods for the assessment of small airways inflammation in asthma
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 344-349
Year: 2008
Exhaled nitric oxide is a useful marker of airway hyperreactivity in patients with chronic cough
Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Year: 2005
Exhaled nitric oxide and lower airway involvement in persistent rhinitis
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers
vs
induced sputum
Year: 2006
Domiciliary exhaled nitric oxide and eosinophilic airway inflammation in adults with asthma
Source: Eur Respir J 2016; 48: 242-244
Year: 2016
The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 366s
Year: 2007
Correlation between cold airway hyperresponsiveness and the content of nitric oxide in the exhaled air in patients with bronchial asthma
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Evaluation of exhaled nitric oxide and sputum eosinophils as markers of inflammation in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 176s
Year: 2003
The use of exhaled nitric oxide concentration as a means of excluding eosinophilic inflammation in chronic cough
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009
Correlation between exhaled nitric oxide, airway hyper responsiveness and pulmonary function data in patients with suspected asthma
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept